Coverart for item
The Resource GI Surgery Annual : Volume 23

GI Surgery Annual : Volume 23

Label
GI Surgery Annual : Volume 23
Title
GI Surgery Annual
Title remainder
Volume 23
Creator
Contributor
Subject
Language
eng
Member of
Cataloging source
MiAaPQ
Literary form
non fiction
Nature of contents
dictionaries
Series statement
GI Surgery Annual Ser.
Series volume
v.23
GI Surgery Annual : Volume 23
Label
GI Surgery Annual : Volume 23
Link
http://libproxy.rpi.edu/login?url=https://ebookcentral.proquest.com/lib/rpi/detail.action?docID=4801200
Publication
Copyright
Related Contributor
Related Location
Related Agents
Related Authorities
Related Subjects
Related Items
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
  • Preface -- About the Editors -- Contents -- Contributors -- Chapter 1: Lymphadenectomy in Oesophageal Carcinoma -- 1.1 Introduction -- 1.2 Basic Model of Cancer Spread -- 1.3 Rationale of Lymphadenectomy -- 1.4 Anatomy of Lymphatic Spread -- 1.5 Definitions -- 1.5.1 Extent of Lymphadenectomy -- 1.5.2 AJCC TNM Staging and Nodal Nomenclature (7th Edition) [15] -- 1.5.3 Japanese Classification of Oesophageal Cancer (10th Edition) [16] -- 1.6 Oncological Outcomes of Lymphadenectomy -- 1.6.1 Recurrence -- 1.7 Long Term Survival -- 1.7.1 Azygous Resection -- 1.7.2 Thoracic Duct Resection -- 1.8 Morbidity and Mortality of Lymphadenectomy -- 1.9 Arguments For and Against Lymphadenectomy -- 1.9.1 Arguments for Lymphadenectomy -- 1.9.2 Arguments Against Lymphadenectomy -- 1.10 Special Situations -- 1.10.1 Relevance of Lymphadenectomy in the Era of Neoadjuvant Therapy -- 1.10.2 Minimally Invasive Oesophagectomy (MIE) and Lymphadenectomy -- 1.11 Guidelines (Specifically Relevant to Lymphadenectomy) -- 1.11.1 NCCN, USA, Guidelines, 2016, Version 1 [131] -- 1.11.2 UK guidelines, 2011 [132] (on behalf of Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, the British Society of Gastroenterology and the British Association of Surgical Oncology) -- 1.11.3 Japan Esophageal Society Guidelines, 2012 [77] -- 1.12 Pragmatic Point of View for the Surgeon -- References -- Chapter 2: Short Bowel Syndrome -- 2.1 Introduction -- 2.2 Aetiology -- 2.3 Post-resection Anatomical and Physiological Considerations -- 2.4 Natural Course of Adaptation and Rehabilitation -- 2.5 Nutrition and Rehabilitation -- 2.6 Pharmacotherapy -- 2.7 Surgical Management -- 2.7.1 Bianchi Procedure (LILT: Longitudinal Intestinal Lengthening and Tailoring) -- 2.7.2 Serial Transverse Enteroplasty (STEP) -- 2.7.3 Spiral Intestinal Lengthening and Tailoring (SILT)
  • 2.7.4 Intestinal Transplantation -- 2.7.5 Complications of Intestinal Transplantation -- 2.7.6 Nutritional Monitoring Post Transplant -- 2.8 Conclusion -- References -- Chapter 3: Postoperative Liver Failure -- 3.1 Introduction -- 3.2 Pathophysiology -- 3.3 Precipitating Factors -- 3.4 Preoperative Risk Assessment -- 3.4.1 Screening Tests -- 3.4.2 Diagnostic Tests -- 3.4.3 Quantitative Tests -- 3.5 Scoring Systems -- 3.6 Imaging -- 3.7 Prevention -- 3.7.1 Hepatoprotective Strategies -- 3.7.2 Recommendations -- 3.7.3 Parenchymal Volume Management -- 3.7.4 Splenic/Portal Inflow Modulation -- 3.7.5 Staged Resections -- 3.7.6 Different Tumour Strategies -- 3.8 Management of PLF -- 3.9 Surgery -- 3.10 Conclusion -- References -- Chapter 4: Xanthogranulomatous Cholecystitis -- 4.1 Introduction -- 4.2 Aetiopathogenesis -- 4.3 Relationship of XGC with GBC -- 4.4 Clinical Presentation -- 4.5 Radiological Assessment -- 4.6 Surgical Management -- 4.7 Histopathology -- 4.8 Our Experience -- References -- Chapter 5: Pancreatic Trauma -- 5.1 Introduction -- 5.2 Aetiology -- 5.2.1 Anatomical Considerations -- 5.2.2 Mechanical Considerations -- 5.2.3 Age -- 5.3 Incidence -- 5.4 Clinical Presentation -- 5.5 Classification -- 5.6 Laboratory Studies -- 5.7 Imaging in Pancreatic Trauma -- 5.7.1 CECT -- 5.7.2 Magnetic Resonance Imaging with MRCP -- 5.7.3 Contrast Enhanced Ultrasound (CEUS) -- 5.7.4 ERCP -- 5.7.5 X-Ray -- 5.8 Evolution of Pancreatic Injury -- 5.9 Management -- 5.9.1 Conservative Management -- 5.9.2 Surgical Management -- 5.9.3 Minor Injuries (Grade I and II) -- 5.9.4 Major Injuries (Grade III to V) -- 5.10 Postoperative Details -- 5.11 Complications -- 5.11.1 Pancreatic Fistula -- 5.11.2 Pseudocyst Formation -- 5.11.3 Vascular Complications -- 5.11.4 Recurrent Pancreatitis -- 5.11.5 Infectious Complications -- 5.11.6 Miscellaneous
  • 5.12 Future and Controversies -- References -- Chapter 6: Controversies in Surgery for Pancreatic Cancer -- 6.1 Controversies: the Top Seven Questions -- 6.1.1 What Is the Natural History of Pancreatic Cancer and the System of Spread of the Disease? -- 6.1.2 Is R0 Resection the Key to Improved Survival? -- 6.1.3 How Can the Resected Margins Be Examined Precisely? -- 6.1.4 Do Vascular Resections Help? -- 6.1.5 Are Multivisceral Resections Justifiable? -- 6.1.6 What Should Be the Extent of Lymphadenectomy? -- 6.1.7 Have Laparoscopic and Robotic Technologies Made a Difference? -- References -- Chapter 7: Splenectomy for Haematological Disorders -- 7.1 Introduction -- 7.2 Indications -- 7.3 Platelet Disorders -- 7.3.1 Immune Thrombocytopenic Purpura (ITP) -- 7.3.2 Thrombotic Thrombocytopenic Purpura (TTP) -- 7.4 Congenital Red Cell Disorders -- 7.4.1 Disorders of Erythrocyte Membranes -- 7.4.2 Haemoglobinopathies -- 7.4.3 Erythrocyte Enzyme Deficiency -- 7.5 Malignancy -- 7.5.1 Hodgkin's Disease -- 7.5.2 Non-Hodgkin's Lymphoma -- 7.5.3 Leukaemia -- 7.5.4 Revised Rai Staging System (United States) -- 7.6 Preoperative Preparation for Splenectomy -- 7.6.1 Splenectomy -- 7.6.2 Open Procedure -- 7.6.3 Laparoscopic Procedure -- 7.7 Postoperative Management -- 7.7.1 Recovery -- 7.7.2 Transfusion of Platelets in ITP -- 7.7.3 Postoperative Platelet Levels -- 7.7.4 Postoperative Immunization -- 7.7.5 Preventive Antibiotic Therapy -- 7.8 Complications of Splenectomy -- 7.9 Our Experience -- 7.9.1 Complications -- References -- Chapter 8: Role of PET-CT in Hepatobiliary Diseases -- 8.1 Introduction -- 8.2 Role in the Evaluation of Hepatic Metastasis -- 8.3 Role in Hepatocellular Carcinoma (HCC) -- 8.3.1 Limitations -- 8.4 Role in Cholangiocarcinoma -- 8.5 Role in Gall Bladder Carcinoma -- 8.5.1 Limitations -- 8.6 Role in Pancreatic Adenocarcinoma
  • 8.6.1 Limitations -- 8.7 Evaluation of Islet Cell and Other Endocrine Tumours of the Pancreas -- 8.8 Benign Liver Tumours -- 8.9 Overall Limitations -- 8.10 Summary -- References -- Chapter 9: Hyperthermic Intraperitoneal Chemotherapy -- 9.1 Introduction and Historical Perspective -- 9.2 Rationale Behind CRS and HIPEC -- 9.3 Rationale Behind Hyperthermia -- 9.4 Rationale Behind Bidirectional Chemotherapy -- 9.5 Rationale Behind Increasing Intra-abdominal Pressure -- 9.6 Role of Type of Carrier Solution and Vasoactive Agents -- 9.7 Open, Semi-closed or Closed Techniques -- 9.8 Types of Intraperitoneal Chemotherapy Regimens -- 9.8.1 Neoadjuvant Intraperitoneal and Intravenous Chemotherapy -- 9.8.2 Intraoperative HIPEC and Intravenous Chemotherapy -- 9.8.3 Early Postoperative Intraperitoneal Chemotherapy (EPIC) -- 9.8.4 Adjuvant Intraperitoneal and Systemic Chemotherapy -- 9.9 Role of Laparoscopy -- 9.10 Procedure of CRS and HIPEC -- 9.11 Drugs Used in HIPEC -- 9.11.1 Appendiceal Tumours and PMP -- 9.11.2 Colorectal Neoplasms -- 9.11.3 Gastric Cancer -- 9.11.4 Malignant Peritoneal Mesothelioma -- 9.12 Monitoring -- 9.13 Complications of CRS and HIPEC -- 9.14 CRS and HIPEC for Colorectal Cancer -- 9.15 CRS and HIPEC for Appendiceal Neoplasms -- 9.15.1 Selection Criteria for CRS and HIPEC for Colorectal and Appendiceal Neoplasms -- 9.15.2 Contraindications to CRS and HIPEC -- 9.16 Concept of Second Look Laparotomy -- 9.16.1 Repeat CRS and HIPEC -- 9.17 CRS and HIPEC for Non-colorectal/Appendical Neoplasms -- 9.18 Our Experience -- 9.19 Conclusion -- References -- Chapter 10: Advances in Gastrointestinal Surgery -- 10.1 Oesophagus -- 10.1.1 Fast Track Oesophagectomy: Is It a Viable Option? -- 10.1.2 Current Understanding of Distal Oesophageal Spasm (DES) -- 10.1.2.1 Aetiopathogenesis -- 10.1.2.2 Clinical Presentation -- 10.1.2.3 Diagnosis
  • 10.1.2.4 Therapeutic Options -- 10.1.3 Oesophageal Cancer -- 10.1.3.1 Extensive Lymphadenectomy: Survival Is No Better -- 10.2 Intestine -- 10.2.1 Management of Postoperative Ileus with Gastrografin -- 10.2.2 Inflammatory Bowel Disease: Biological Therapy and Its Complications -- 10.2.2.1 Infectious Complications -- 10.2.2.2 Malignancies and Anti-TNF Therapy -- 10.2.2.3 Miscellaneous Complications -- 10.2.3 Recent Trends in the Management of Acute Diverticulitis -- 10.3 Liver -- 10.3.1 Quantitative Liver Function Tests (QLFT): Need of the Hour -- 10.3.1.1 Utility of QLFT -- 10.3.2 Porto-Pulmonary Hypertension -- 10.3.3 Hepatopulmonary Syndrome: Its Pathogenesis, Diagnosis and Management -- 10.3.4 Organ Transplantation and Infection -- 10.3.5 Acute Liver Failure -- 10.3.6 Contemporary Issues in Liver Transplantation -- 10.3.6.1 MELD Score and Prognosis -- 10.3.6.2 Transplantation in Various Categories -- 10.4 Biliary -- 10.4.1 IgG Cholangiopathy -- 10.4.2 Pathogenesis of Carcinoma of the Gall Bladder -- 10.4.3 Extrahepatic Bile Duct (EHBD) and Gall Bladder (GB) Cancer -- 10.4.3.1 Adjuvant Chemoradiotherapy -- 10.5 Pancreas -- 10.5.1 Newer Scoring Systems for Assessment of Severity of Acute Pancreatitis and Its Management -- 10.6 Miscellaneous -- 10.6.1 Closure of the Midline Abdominal Incision: Do We Need to Change the Way It Is Done? -- References -- Oesophagus -- Fast Track Oesophagectomy: Is It a Viable Option? -- Current Understanding of Distal Oesophageal Spasm (DES) -- Oesophageal Cancer -- Intestine -- Management of Postoperative Ileus with Gastrografin -- Inflammatory Bowel Disease: Biological Therapy and Its Complications -- Recent Trends in the Management of Acute Diverticulitis -- Liver -- Quantitative Liver Function Tests (QLFT): Need of the Hour -- Porto-Pulmonary Hypertension
  • Hepatopulmonary Syndrome: Its Pathogenesis, Diagnosis and Management
http://library.link/vocab/cover_art
https://contentcafe2.btol.com/ContentCafe/Jacket.aspx?Return=1&Type=S&Value=9789811026782&userID=ebsco-test&password=ebsco-test
Dimensions
unknown
http://library.link/vocab/discovery_link
{'f': 'http://opac.lib.rpi.edu/record=b4387449'}
Extent
1 online resource (247 pages)
Form of item
online
Isbn
9789811026782
Media category
computer
Media MARC source
rdamedia
Media type code
c
Sound
unknown sound
Specific material designation
remote

Library Locations

    • Folsom LibraryBorrow it
      110 8th St, Troy, NY, 12180, US
      42.729766 -73.682577
Processing Feedback ...